SCHEMBL258083

SCHEMBL258083

CCCCCCCCCCCCC(O)(O)CCOS(=O)(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 8/20 0.40
CA2 P00918 8/20 0.40
CA9 Q16790 7/20 0.40
CA12 O43570 3/20 0.40
CA7 P43166 3/20 0.40
CA14 Q9ULX7 3/20 0.40
CA3 P07451 2/20 0.40
CA4 P22748 2/20 0.40
CA6 P23280 2/20 0.40
CA5A P35218 2/20 0.40
CA5B Q9Y2D0 2/20 0.40
SMPD1 P17405 1/20 0.40
FDPS P14324 8/20 0.39
GGPS1 O95749 5/20 0.39
RECQL P46063 2/20 0.39
GLA P06280 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
EPHX2 P34913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30379450 0.84 SMPD1 (0.41) CA1CA2CA9CA12CA7
SCHEMBL258035 0.83 RECQL (0.62) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19811831 0.81 CA1 (0.43) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19811316 0.81 CA1 (0.47) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19810926 0.81 CA1 (0.43) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19811770 0.81 CA1 (0.47) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19811059 0.81 CA1 (0.43) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19811421 0.81 CA1 (0.47) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19811957 0.81 CA1 (0.47) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19811809 0.81 CA1 (0.43) CA1CA2CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968607-B2 Cosmetics 1-isostearylglycerol-3-Sulfate Sodium Salt, used for constriction of keratinocytes; aging resistance KOA CORPORATION (JP) 2011-06-28 US disclosed
US-20080234390-A1 SKIN PORE MINIMIZERS AND SKIN ELASTICITY IMPROVERS KAO CORPORATION (JP) 2008-09-25 US disclosed
US-20040009140-A1 Skin pore minimizers and skin elasticity improvers KAO CORPORATION (JP) 2004-01-15 US disclosed
EP-1325737-A1 SKIN PORE MINIMIZERS AND SKIN ELASTICITY IMPROVERS Kao Corporation (JP) 2003-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009140-A1 Skin pore minimizers and skin elasticity improvers CUTA, DSG1, OGA CA1 3912/4885CA2 1387/4885CA9 2769/4885
US-20080234390-A1 SKIN PORE MINIMIZERS AND SKIN ELASTICITY IMPROVERS DSG1, CUTA, OGA CA1 3615/4885CA2 1275/4885CA9 2320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.